Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1998 Apr;35(4):328–332. doi: 10.1136/jmg.35.4.328

Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation.

E K Pivnick 1, W L Furman 1, G V Velagaleti 1, J J Jenkins 1, N A Chase 1, R C Ribeiro 1
PMCID: PMC1051284  PMID: 9598730

Abstract

The predisposition to malignancy that is dominantly inherited in Li-Fraumeni syndrome is associated with germline mutations of the tumour suppressor gene p53. Although second malignant neoplasms have been described in children with p53 mutations, the synchronous occurrence of two embryologically different tumours in these children has not been reported. A 20 month old girl with failure to thrive and congenital heart defects was found to have unilateral adrenal masses which, at surgical removal, proved to be an adrenocortical carcinoma and a ganglioneuroblastoma. Further investigation showed a germline p53 mutation and Turner syndrome. It remains to be determined what effect the 45,X chromosomal complement may have on the expression of neoplasms seen in patients with p53 germline mutations.

Full text

PDF
328

Images in this article

329Image
on p.329
329Image
on p.329
329Image
on p.329
329Image
on p.329
329Image
on p.329
330Image
on p.330
330Image
on p.330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellah R., D'Andrea A., Darillis E., Fellows K. E. The association of congenital neuroblastoma and congenital heart disease. Is there a common embryologic basis? Pediatr Radiol. 1989;19(2):119–121. doi: 10.1007/BF02387900. [DOI] [PubMed] [Google Scholar]
  2. Birch J. M. Li-Fraumeni syndrome. Eur J Cancer. 1994;30A(13):1935–1941. doi: 10.1016/0959-8049(94)00383-g. [DOI] [PubMed] [Google Scholar]
  3. Brown C. J. Role of the X chromosome in cancer. J Natl Cancer Inst. 1996 Apr 17;88(8):480–482. doi: 10.1093/jnci/88.8.480. [DOI] [PubMed] [Google Scholar]
  4. Davidoff A. M., Pence J. C., Shorter N. A., Iglehart J. D., Marks J. R. Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene. 1992 Jan;7(1):127–133. [PubMed] [Google Scholar]
  5. Diller L., Friend S. H. Identification of cancer-prone individuals: p53 and family cancer syndromes. J Natl Cancer Inst Monogr. 1992;(12):123–124. [PubMed] [Google Scholar]
  6. FRASIER S. D., BASHORE R. A., MOSIER H. D. GONADOBLASTOMA ASSOCIATED WITH PURE GONADAL DYSGENESIS IN MONOZYGOUS TWINS. J Pediatr. 1964 May;64:740–745. doi: 10.1016/s0022-3476(64)80622-3. [DOI] [PubMed] [Google Scholar]
  7. Ferrier P. E., Ferrier S. A., Schärer K. O., Genton N., Hedinger C., Klein D. Disturbed gonadal differentiation in a child with X0-XY-XYY mosaicism: relationship with gonadoblastoma. Helv Paediatr Acta. 1967 Oct;22(5):479–490. [PubMed] [Google Scholar]
  8. Gough N. M., Gearing D. P., Nicola N. A., Baker E., Pritchard M., Callen D. F., Sutherland G. R. Localization of the human GM-CSF receptor gene to the X-Y pseudoautosomal region. Nature. 1990 Jun 21;345(6277):734–736. doi: 10.1038/345734a0. [DOI] [PubMed] [Google Scholar]
  9. Gøtzsche C. O., Krag-Olsen B., Nielsen J., Sørensen K. E., Kristensen B. O. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child. 1994 Nov;71(5):433–436. doi: 10.1136/adc.71.5.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HADDAD H. M., WILKINS L. Congenital anomalies associated with gonadal aplasia; review of 55 cases. Pediatrics. 1959 May;23(5):885–902. [PubMed] [Google Scholar]
  11. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 1991 Jul 5;253(5015):49–53. doi: 10.1126/science.1905840. [DOI] [PubMed] [Google Scholar]
  12. Kasperlik-Załuska A. A., Migdalska B. M., Zgliczyński S., Makowska A. M. Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer. 1995 May 15;75(10):2587–2591. doi: 10.1002/1097-0142(19950515)75:10<2587::aid-cncr2820751028>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  13. Knudson A. G., Jr, Strong L. C., Anderson D. E. Heredity and cancer in man. Prog Med Genet. 1973;9:113–158. [PubMed] [Google Scholar]
  14. LEMLI L., SMITH D. W. THE XO SYNDROME. A STUDY OF THE DIFFERENTIATED PHENOTYPE IN 25 PATIENTS. J Pediatr. 1963 Oct;63:577–588. doi: 10.1016/s0022-3476(63)80368-6. [DOI] [PubMed] [Google Scholar]
  15. Li F. P., Fraumeni J. F., Jr, Mulvihill J. J., Blattner W. A., Dreyfus M. G., Tucker M. A., Miller R. W. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988 Sep 15;48(18):5358–5362. [PubMed] [Google Scholar]
  16. Li F. P., Fraumeni J. F., Jr Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969 Oct;71(4):747–752. doi: 10.7326/0003-4819-71-4-747. [DOI] [PubMed] [Google Scholar]
  17. Luton J. P., Cerdas S., Billaud L., Thomas G., Guilhaume B., Bertagna X., Laudat M. H., Louvel A., Chapuis Y., Blondeau P. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med. 1990 Apr 26;322(17):1195–1201. doi: 10.1056/NEJM199004263221705. [DOI] [PubMed] [Google Scholar]
  18. Malkin D., Jolly K. W., Barbier N., Look A. T., Friend S. H., Gebhardt M. C., Andersen T. I., Børresen A. L., Li F. P., Garber J. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992 May 14;326(20):1309–1315. doi: 10.1056/NEJM199205143262002. [DOI] [PubMed] [Google Scholar]
  19. Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Jr, Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990 Nov 30;250(4985):1233–1238. doi: 10.1126/science.1978757. [DOI] [PubMed] [Google Scholar]
  20. Malkin D. p53 and the Li-Fraumeni syndrome. Cancer Genet Cytogenet. 1993 Apr;66(2):83–92. doi: 10.1016/0165-4608(93)90233-c. [DOI] [PubMed] [Google Scholar]
  21. Michalkiewicz E. L., Sandrini R., Bugg M. F., Cristofani L., Caran E., Cardoso A. M., de Lacerda L., Ribeiro R. C. Clinical characteristics of small functioning adrenocortical tumors in children. Med Pediatr Oncol. 1997 Mar;28(3):175–178. doi: 10.1002/(sici)1096-911x(199703)28:3<175::aid-mpo3>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  22. Miyabara S., Sugihara H., Maehara N., Shouno H., Tasaki H., Yoshida K., Saito N., Kayama F., Ibara S., Suzumori K. Significance of cardiovascular malformations in cystic hygroma: a new interpretation of the pathogenesis. Am J Med Genet. 1989 Dec;34(4):489–501. doi: 10.1002/ajmg.1320340408. [DOI] [PubMed] [Google Scholar]
  23. Nielsen J., Wohlert M. Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig Artic Ser. 1990;26(4):209–223. [PubMed] [Google Scholar]
  24. Nitschke R., Smith E. I., Shochat S., Altshuler G., Travers H., Shuster J. J., Hayes F. A., Patterson R., McWilliams N. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol. 1988 Aug;6(8):1271–1279. doi: 10.1200/JCO.1988.6.8.1271. [DOI] [PubMed] [Google Scholar]
  25. RAINIER-POPE C. R., CUNNINGHAM R. D., NADAS A. S., CRIGLER J. F., Jr CARDIOVASCULAR MALFORMATION IN TURNER'S SYNDROME. Pediatrics. 1964 Jun;33:919–925. [PubMed] [Google Scholar]
  26. Ribeiro R. C., Sandrini Neto R. S., Schell M. J., Lacerda L., Sambaio G. A., Cat I. Adrenocortical carcinoma in children: a study of 40 cases. J Clin Oncol. 1990 Jan;8(1):67–74. doi: 10.1200/JCO.1990.8.1.67. [DOI] [PubMed] [Google Scholar]
  27. Rosti L., Lin A. E., Frigiola A. Neuroblastoma and congenital cardiovascular malformations. Pediatrics. 1996 Feb;97(2):258–261. [PubMed] [Google Scholar]
  28. Sameshima Y., Tsunematsu Y., Watanabe S., Tsukamoto T., Kawa-ha K., Hirata Y., Mizoguchi H., Sugimura T., Terada M., Yokota J. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. J Natl Cancer Inst. 1992 May 6;84(9):703–707. doi: 10.1093/jnci/84.9.703. [DOI] [PubMed] [Google Scholar]
  29. Santibáez-Koref M. F., Birch J. M., Hartley A. L., Jones P. H., Craft A. W., Eden T., Crowther D., Kelsey A. M., Harris M. p53 germline mutations in Li-Fraumeni syndrome. Lancet. 1991 Dec 14;338(8781):1490–1491. doi: 10.1016/0140-6736(91)92303-j. [DOI] [PubMed] [Google Scholar]
  30. Similä S., Jukarainen E., Herva R., Heikkinen E. S. Gonadoblastoma associated with pure gonadal dysgenesis. Report of a 10-year-old girl with 46, XY karyotype. Clin Pediatr (Phila) 1974 Feb;13(2):177–180. doi: 10.1177/000992287401300211. [DOI] [PubMed] [Google Scholar]
  31. Srivastava S., Zou Z. Q., Pirollo K., Blattner W., Chang E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990 Dec 20;348(6303):747–749. doi: 10.1038/348747a0. [DOI] [PubMed] [Google Scholar]
  32. Strauss E. A., Hosler M. R., Herzog P., Salhany K., Louie R., Felix C. A. Complex replication error causes p53 mutation in a Li-Fraumeni family. Cancer Res. 1995 Aug 1;55(15):3237–3241. [PubMed] [Google Scholar]
  33. Wagner J., Portwine C., Rabin K., Leclerc J. M., Narod S. A., Malkin D. High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst. 1994 Nov 16;86(22):1707–1710. doi: 10.1093/jnci/86.22.1707. [DOI] [PubMed] [Google Scholar]
  34. Wang M. G., Zakut R., Yi H., Rosenberg S., McBride O. W. Localization of the MAGE1 gene encoding a human melanoma antigen to chromosome Xq28. Cytogenet Cell Genet. 1994;67(2):116–119. doi: 10.1159/000133810. [DOI] [PubMed] [Google Scholar]
  35. Wertelecki W., Fraumeni J. F., Jr, Mulvihill J. J. Nongonadal neoplasia in Turner's syndrome. Cancer. 1970 Aug;26(2):485–488. doi: 10.1002/1097-0142(197008)26:2<485::aid-cncr2820260233>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  36. Wooten M. D., King D. K. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer. 1993 Dec 1;72(11):3145–3155. doi: 10.1002/1097-0142(19931201)72:11<3145::aid-cncr2820721105>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES